Patrick Roddy Greer, MD | |
155 Hospital Rd, Suite D, Winchester, TN 37398-2494 | |
(931) 967-8055 | |
Not Available |
Full Name | Patrick Roddy Greer |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 155 Hospital Rd, Winchester, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104862358 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | MD0000011992 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Patrick Roddy Greer, MD 155 Hospital Rd Ste D, Winchester, TN 37398-2495 Ph: (931) 967-8055 | Patrick Roddy Greer, MD 155 Hospital Rd, Suite D, Winchester, TN 37398-2494 Ph: (931) 967-8055 |
News Archive
Send Word Now, the leading provider of emergency notification and on-demand alerting and response services, announced today that Unity Health System, a 681-bed health-care network based out of Rochester, New York, has selected Send Word Now to provide emergency voice and text communication services to its hospitals.
In this interview, Tim Cross, Director of the NMR and MRI programs at the National High Magnetic Field Lab (NHMFL) in Tallahassee, Florida, talks about his research into protein structures in viruses and bacteria, and how the findings will affect medical research into disease prevention.
A large nationwide study that includes neurologists from Mayo Clinic has found that blacks are substantially less likely than whites to know that they have atrial fibrillation or to use warfarin, the most common treatment for the condition. Atrial fibrillation, an abnormal heart rhythm, significantly increases risk of stroke. Warfarin is known to reduce that risk.
A leader in the fight against brain diseases and in drug discovery to help Alzheimer's patients has joined the University of Florida College of Medicine, interim dean Michael Good, M.D., announced.
CEL-SCI Corporation announced today that it has commenced its Phase III clinical trial for Multikine®, the Company's flagship immunotherapy, at the National Institute of Oncology in Budapest, Hungary. Enrollment is expected to start soon in this center. The study is already ongoing at twelve clinical sites in the United States, Canada, Poland and India.
› Verified 2 days ago
Clive Anderson Wasson, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 83 Memorial Dr, Winchester, TN 37398 Phone: 931-967-3966 Fax: 931-962-0373 | |
Troy Andrew Hixson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 83 Memorial Dr, Winchester, TN 37398 Phone: 931-967-3966 Fax: 931-962-0373 | |
Dr. Damian T Szewczyk, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 83 Memorial Dr, Winchester, TN 37398 Phone: 931-967-3966 Fax: 931-962-0373 |